Lifecore Biomedical
LFCR
LFCR
68 hedge funds and large institutions have $132M invested in Lifecore Biomedical in 2023 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 17 increasing their positions, 19 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
43% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 14
63% less capital invested
Capital invested by funds: $358M → $132M (-$225M)
Holders
68
Holding in Top 10
4
Calls
$2.05M
Puts
$1.89M
Top Buyers
| 1 | +$2.36M | |
| 2 | +$1.79M | |
| 3 | +$1.24M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$577K |
| 5 |
TI
Trexquant Investment
Stamford,
Connecticut
|
+$356K |
Top Sellers
| 1 | -$3.47M | |
| 2 | -$1.18M | |
| 3 | -$986K | |
| 4 |
State of Wisconsin Investment Board
Madison,
Wisconsin
|
-$520K |
| 5 |
E
Ergoteles
New York
|
-$494K |